With the evidence that protamine has little to no interactions with the basolateral membrane transporters OAT-1, OAT-3, and OCT-2, the question still remains of how protamine interacts with vancomycin to delay the onset of AKI when co-administered with vancomycin. The gene discussed is SLC22A2; the disease is acute kidney injury.